Bandingkan Harga & Kinerja Elang Mahkota Teknologi Tbk. (EMTK) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Elang Mahkota Teknologi Tbk. dan Tempo Scan Pacific Tbk.: Elang Mahkota Teknologi Tbk. diperdagangkan di Rp515 (kapitalisasi pasar 31,94 T, volume 24 jam 23,61 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.520 (kapitalisasi pasar 11,18 T, volume 24 jam 613 rb). Perbedaan utamanya: Elang Mahkota Teknologi Tbk. jauh lebih besar — sekitar 2,9× kapitalisasi pasar Tempo Scan Pacific Tbk., dan Elang Mahkota Teknologi Tbk. lebih aktif diperdagangkan (23,61 jt vs 613 rb). Mana yang lebih baik tergantung tujuan investasimu.
| EMTK | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 31,94 T | 11,18 T |
Volume | 23,61 jt | 613 rb |
Lot | 236,13 rb | 6,13 rb |
Perputaran | 12,22 M | 1,54 M |
Harga Rata-rata | 517,66 | 2.511,52 |
Nilai Transaksi | 12,22 M | 1,54 M |
Harga Ekuilibrium Indikatif | 515 | 2.520 |
Volume Ekuilibrium Indikatif | 8,64 rb | 17 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Elang Mahkota Teknologi Tbk.
PT Elang Mahkota Teknologi Tbk (the Company) was established based on Notarial Deed No.7 dated August 3, 1983 of Soetomo Ramelan, S.H.. The Company is engaged in services, specifically in providing technology, media, and telecommunication services, trading, construction, and industry. Company started its commercial operation in 1984.
Selengkapnya di halaman EMTK →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
